首页 | 本学科首页   官方微博 | 高级检索  
     检索      

拉米夫定治疗早中期慢性重型肝炎及血清TGF-β_1、TNF-α的变化
引用本文:徐建中,徐立新,赵云.拉米夫定治疗早中期慢性重型肝炎及血清TGF-β_1、TNF-α的变化[J].大连大学学报,2006,27(4).
作者姓名:徐建中  徐立新  赵云
作者单位:南通市第三人民医院,江苏,南通,226006
摘    要:目的]探讨拉米夫定治疗早、中期慢性重型肝炎的疗效,观察血清TNF-α、TGF-β1的变化.方法]121例早、中期慢性重型肝炎患者分两组,均以综合治疗为主,治疗组加用拉米夫定100 mg,每日1次,共2个月.比较两组患者治疗前后肝功能,HBeAg、HBV-DNA、TGF-β1、TNF-α的变化,及病死率的差异.结果]治疗组患者血清HBeAg,HBV-DNA转阴明显高于对照组,血清总胆红素,TNF-α、TGF-β1较对照组下降明显,病死率也下降.结论]慢性重型肝炎早、中期应该尽早应用抗病毒药物,这对减少慢性重型肝炎的病死率有益.

关 键 词:慢性重型肝炎  拉米夫定TNF-α、TGF-β1

Lamivudine treatment for early and developmental chronic severe hepatitis and observation of serum TGF-β1、TNF-α
XU Jian-zhong,XU Li-xin,ZHAO Yun.Lamivudine treatment for early and developmental chronic severe hepatitis and observation of serum TGF-β1、TNF-α[J].Journal of Dalian University,2006,27(4).
Authors:XU Jian-zhong  XU Li-xin  ZHAO Yun
Abstract:Objective] To investigate the effect of lamivudine treatment for early and developmental chronic severe hepatitis and observe the changing of serum TGF-β1、TNF-α.Methods]from may 2000 to may 2005,a total of 121 patients with early and developmental chronic severe hepatitis were studied prospectively.Of them 56 patients were received 100mg lamivudine per day for two months besides other routine treatments,and compared with remaining 65 patients who received routine treatments.Mortality and some serum parameter such us liver function,HBeAg,HBV-DNA,TGF-β1、TNF-αwere investigated.Results] HBeAg and HBV-DNA seroconversion in treatment group was higher than that in routine group,mortality and some parameter such as serum bilirubin,TGF-β1、TNF-αwere lower in treatment group than in routine group.Conclusion]Anti-virus drugs such as lamividine should be used early in early and developmental chronic severe hepatitis so that it can reduced mortality and benefits those patients.
Keywords:chronic severe hepatitis  lamividine TGF-β1、TNF-α
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号